SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-08-002792
Filing Date
2008-08-11
Accepted
2008-08-11 16:01:32
Documents
9
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w65275e10vq.htm 10-Q 458771
2 EXHIBIT 10.3 w65275exv10w3.htm EX-10.3 9458
3 EXHIBIT 10.4 w65275exv10w4.htm EX-10.4 152924
4 EXHIBIT 10.5 w65275exv10w5.htm EX-10.5 16233
5 EXHIBIT 10.6 w65275exv10w6.htm EX-10.6 15747
6 EXHIBIT 31.1 w65275exv31w1.htm EX-31.1 8402
7 EXHIBIT 31.2 w65275exv31w2.htm EX-31.2 5767
8 EXHIBIT 32.1 w65275exv32w1.htm EX-32.1 3132
9 EXHIBIT 32.2 w65275exv32w2.htm EX-32.2 3149
  Complete submission text file 0000950133-08-002792.txt   674989
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 081006218
SIC: 2836 Biological Products, (No Diagnostic Substances)